TSPO and Alzheimer disease: Deficiencies in the function of serotonin transporters are also noted in transgenic mouse models of AD; increases in neuroinflammatory markers, translocator protein (TSPO, 18kDa), and IL-1β were observed to precede a reduction in serotonin-transporter density and activity, as shown by Mataxas et al. [29].